The FDA says women who are taking Veozah may need more frequent blood testing to check for markers of liver problems. In rare cases, the drug may seriously injure the liver, and patients with ...

Last week, the Food and Drug Administration (FDA) released a “Drug Safety Communication,” warning that Veozah (fezolinetant), a new medicine to treat hot flashes due to menopause, can cause ...

This chemical causes vasomotor symptoms, or hot flashes and night sweats. Veozah blocks the chemical NKB, reducing night sweats and hot flashes. Studies looked at how Veozah affected how ...

The U.S. Food and Drug Administration (FDA) has issued its most serious warning -- a black-box warning -- for Veozah, a ...

FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning By Denise Maher HealthDay Reporter WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA ...

The FDA has added a boxed warning to the labeling of Veozah, a medication used to treat hot flashes, highlighting a rare but serious risk of liver injury. The agency added recommendations for ...

VEOZAH is not a hormone. VMS are the feelings of warmth in the face, neck, and chest, or sudden intense feelings of heat and sweating ("hot flashes" or "hot flushes"). VEOZAH works by blocking ...

MARKHAM, ON, March 18, 2025 /CNW/ - Today, Astellas Pharma Canada, Inc. is pleased to announce that VEOZAH ® (fezolinetant film-coated tablets) is now available in pharmacies across Canada for ...

The FDA has issued a black-box warning for Veozah, a hot-flash medication, due to rare but serious liver risks Regular liver testing is recommended during Veozah treatment to ensure early ...